EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: An open-label proof-of-concept study

Emmanuelle Bardin, Hélène Salvator, Camille Roquencourt, Elodie Lamy, Nicolas Hunzinger, Isabelle Sermet-Gaudelus, Sandra De Miranda, Dominique Grenet, Philippe Devillier, Stanislas Grassin-Delyle

Journal of Cystic Fibrosis · 2026

DOI: 10.1016/j.jcf.2026.06.013 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Cystic Fibrosis, 2026. Verfasst von Emmanuelle Bardin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Paris, France; Université Paris-Saclay, UVSQ, INSERM, Infection e…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Breath Tests, Metabolomics, Drug Monitoring. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Defeating Cystic Fibrosis Association, European Cystic Fibrosis Society, Île-de-France Regional Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Highly effective CFTR modulators, particularly elexacaftor/tezacaftor/ivacaftor (ETI), produce rapid clinical improvements in people with cystic fibrosis. Yet early effects may be difficult to capture with spirometry or sweat test in patients with a mild disease or atypical mutations. Exhaled breath is rich in volatile organic compounds (VOCs) reflecting metabolic and inflammatory processes. We aimed to determine whether ETI induces early, measurable changes in breath composition and whether these relate to clinical outcomes. METHODS: Ten adults initiating ETI were enrolled in a prospective, open-label study with breath sampling at baseline, week one and month one. VOCs were measured using real-time proton-transfer-reaction - mass spectrometry (PTR-MS). Longitudinal changes were assessed using multilevel statistics, including univariate linear mixed-effects models, and multivariate repeated measures ANOVA-simultaneous component analysis plus (RM-ASCA+); repeated-measures correlations examined associations with lung function and sweat chloride concentration. Results were compared with a healthy cohort. RESULTS: Amongst the eight clinical responders, 11 features changed significantly after ETI initiation. Eight differed from healthy controls at baseline and shifted towards healthy levels over one month. RM-ASCA+ identified monotonous and non-monotonous patterns capturing various dynamics such as acute, progressive or delayed metabolic responses. A 11-feature PLS-DA model classified visits with high accuracy (AUC=0.84-0.96). Ten VOCs correlated with clinical readouts. Tentatively identified features pointed towards a shift in the microbiome and/or energy metabolism. CONCLUSIONS: ETI induces rapid alterations in exhaled VOCs, many trending towards healthy values and correlating with clinical improvement. Real-time breath analysis offers a promising non-invasive surrogate for early monitoring of therapeutic response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisBreath TestsMetabolomicsDrug MonitoringChloride Channel AgonistsProof of Concept StudyCystic Fibrosis Transmembrane Conductance RegulatorHumansMaleFemaleAdultVolatile Organic CompoundsTreatment OutcomeLongitudinal StudiesProspective StudiesMass SpectrometryCase-Control StudiesDrug CombinationsQuinolinesPyrazolesBenzodioxolesIndolesPyridinesAminophenols

Stichwörter der Autor:innen

BreathomicsCFTR modulatorsCystic fibrosisReal-time mass spectrometryVolatile organic compounds

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorVolatile Organic Compoundselexacaftor, ivacaftor, tezacaftor drug combinationChloride Channel AgonistsDrug CombinationsQuinolinesPyrazolesBenzodioxolesIndolesPyridines

Autor:innen und Institutionen

  • Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Paris, France; Université Paris-Saclay, UVSQ, INSERM, Infection et inflammation (2I), U1173, Département de Biotechnologie de la Santé,…
  • Hôpital Foch, Exhalomics®, Suresnes, France; Université Paris-Saclay, UVSQ, UFR Simone Veil-Santé, VIM-Suresnes, UMR0892, Suresnes, France; Hôpital Foch, Service de pneumologie, CRCM - Centre de Transplantation Pulmonai…
  • Université Paris-Saclay, UVSQ, INSERM, Infection et inflammation (2I), U1173, Département de Biotechnologie de la Santé, Unité Technologies pour la Santé et le Médicament, Montigny le Bretonneux, France; Hôpital Foch, E…
  • Université Paris-Saclay, UVSQ, INSERM, Infection et inflammation (2I), U1173, Département de Biotechnologie de la Santé, Unité Technologies pour la Santé et le Médicament, Montigny le Bretonneux, France.
  • Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Paris, France; Hôpital Necker Enfants Malades, Centre de Référence Maladies Rares, Paris, France.
  • Hôpital Foch, Service de pneumologie, CRCM - Centre de Transplantation Pulmonaire, Suresnes, France.

Förderung

  • Defeating Cystic Fibrosis Association
  • European Cystic Fibrosis Society
  • Île-de-France Regional Council

Zitieren

APA

Bardin, E., Salvator, H., Roquencourt, C., Lamy, E., Hunzinger, N., Sermet-Gaudelus, I., De Miranda, S., Grenet, D., Devillier, P., & Grassin-Delyle, S. (2026). Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: An open-label proof-of-concept study. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2026.06.013

Vancouver

Bardin E, Salvator H, Roquencourt C, Lamy E, Hunzinger N, Sermet-Gaudelus I, et al. Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: An open-label proof-of-concept study. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2026.06.013

BibTeX
@article{Bardin2026,
  author = {Bardin, Emmanuelle and Salvator, Hélène and Roquencourt, Camille and Lamy, Elodie and Hunzinger, Nicolas and Sermet-Gaudelus, Isabelle and De Miranda, Sandra and Grenet, Dominique and Devillier, Philippe and Grassin-Delyle, Stanislas},
  title = {Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: An open-label proof-of-concept study},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  doi = {10.1016/j.jcf.2026.06.013}
}
Kostenlos starten →